Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 122,470,452
- Total 13F shares
- 51,955,193
- Share change
- -887,054
- Total reported value
- $791,285,512
- Put/Call ratio
- 87%
- Price per share
- $15.23
- Number of holders
- 191
- Value change
- -$15,709,425
- Number of buys
- 99
- Number of sells
- 84
Quarterly Holders Quick Answers
What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969F109:
Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
8.1%
|
9,900,341
|
$186,918,439 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4%
|
4,904,513
|
$92,597,205 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
4,791,244
|
$90,458,686 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
3.9%
|
4,779,269
|
$90,232,599 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
2.4%
|
2,883,657
|
$54,443,444 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.6%
|
1,914,932
|
$36,153,916 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
1,621,409
|
$30,612,202 | — | 31 Mar 2024 | |
| Invus Financial Advisors, LLC |
13F
|
Company |
1.3%
|
1,612,077
|
$30,436,014 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.3%
|
1,602,200
|
$30,249,536 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.98%
|
1,201,021
|
$22,675,276 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.96%
|
1,171,968
|
$22,130,216 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.94%
|
1,151,128
|
$21,733,297 | — | 31 Mar 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.78%
|
957,304
|
$18,073,900 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.71%
|
874,882
|
$16,517,781 | — | 31 Mar 2024 | |
| Decheng Capital LLC |
13F
|
Company |
0.71%
|
869,790
|
$16,421,635 | — | 31 Mar 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.56%
|
685,025
|
$12,933,000 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.45%
|
547,474
|
$10,336,309 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
513,498
|
$9,694,843 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.4%
|
493,276
|
$9,313,051 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
400,169
|
$7,555,191 | — | 31 Mar 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.32%
|
390,299
|
$7,368,845 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.31%
|
379,100
|
$7,157,000 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.31%
|
378,063
|
$7,137,829 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.29%
|
354,921
|
$6,700,909 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.28%
|
339,667
|
$6,412,913 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.26%
|
316,127
|
$5,968,478 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.26%
|
315,051
|
$5,948,163 | — | 31 Mar 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.24%
|
296,570
|
$5,599,242 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.24%
|
289,965
|
$5,474,539 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.21%
|
263,277
|
$4,970,670 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.21%
|
259,920
|
$4,907,290 | — | 31 Mar 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.21%
|
259,372
|
$4,891,756 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
250,313
|
$4,725,909 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
240,500
|
$4,541,000 | — | 31 Mar 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
240,000
|
$4,531,200 | — | 31 Mar 2024 | |
| AXA S.A. |
13F
|
Company |
0.19%
|
232,072
|
$4,381,519 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.19%
|
231,717
|
$4,374,817 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.17%
|
208,729
|
$3,940,804 | — | 31 Mar 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.17%
|
204,398
|
$3,859,034 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.16%
|
190,683
|
$3,600,095 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
187,871
|
$3,547,004 | — | 31 Mar 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.14%
|
174,655
|
$3,297,490 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
172,673
|
$3,260,040 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.13%
|
165,000
|
$3,115,200 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.12%
|
150,252
|
$2,836,759 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
149,552
|
$2,823,543 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.1%
|
127,219
|
$2,401,895 | — | 31 Mar 2024 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.09%
|
111,846
|
$2,111,652 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.08%
|
103,860
|
$1,960,876 | — | 31 Mar 2024 | |
| York State Teachers Retirement System New |
13F
|
Individual |
0.08%
|
99,751
|
$1,883,000 | — | 31 Mar 2024 |
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q2 2024
As of 30 Jun 2024,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
191 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,955,193 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Woodline Partners LP, FMR LLC, STATE STREET CORP, Point72 Asset Management, L.P., Invus Financial Advisors, LLC, Boxer Capital, LLC, DIMENSIONAL FUND ADVISORS LP, and AMERIPRISE FINANCIAL INC.
This page lists
191
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
169
Q2 2024 holders
191
Holder diff
22
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.